Literature DB >> 16023229

Eplerenone suppresses neointimal formation after coronary stent implantation in swine.

Kohei Wakabayashi1, Hiroshi Suzuki, Takatoshi Sato, Yoshitaka Iso, Takashi Katagiri, Youichi Takeyama.   

Abstract

BACKGROUND: Enhanced extracellular matrix accumulation rather than cell proliferation contributes to later stages of in-stent restenosis. Aldosterone itself has been shown to increase cardiovascular fibrosis, therefore, we studied the suppressive effects of eplerenone, a new aldosterone receptor antagonist, on neointimal hyperplasia after coronary stent implantation in swine.
METHODS: Palmatz-Shatz stents were implanted in the left anterior descending artery of 36 pigs. One hundred milligrams of Eplerenone was orally administered from 1 week before, to 4 weeks after stent implantation in Group E (n=18), and vehicle was given to Group C (n=18). Pigs were sacrificed 1 or 4 weeks after stent implantation. The number of infiltrating macrophages was calculated at 1 week. Morphometrical analysis was performed to measure the area of each layer, and %area of fibrosis and mRNA for collagen I, III and TGF-beta was analyzed by RT-PCR at 4 weeks.
RESULTS: The number of infiltrating macrophages was less in Group E than in Group C (p<0.01). The overall size of coronary arteries at 4 weeks was similar in both groups. However, the luminal area was larger in Group E than in Group C (p<0.05), and the intimal area was smaller in Group E than in Group C (p<0.05). The %area of fibrosis was significantly less in Group E than in Group C at 4 weeks (p<0.01). In Group E, the expression of mRNA for collagen I, III and TGF-beta was significantly reduced.
CONCLUSION: Orally administered eplerenone attenuated collagen accumulation within the neointima, thereby inhibiting neointimal hyperplasia after stent implantation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16023229     DOI: 10.1016/j.ijcard.2005.03.078

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  10 in total

1.  Placental growth factor mediates aldosterone-dependent vascular injury in mice.

Authors:  Iris Z Jaffe; Brenna G Newfell; Mark Aronovitz; Najwa N Mohammad; Adam P McGraw; Roger E Perreault; Peter Carmeliet; Afshin Ehsan; Michael E Mendelsohn
Journal:  J Clin Invest       Date:  2010-11       Impact factor: 14.808

Review 2.  Mineralocorticoid receptors in vascular function and disease.

Authors:  Amy McCurley; Iris Z Jaffe
Journal:  Mol Cell Endocrinol       Date:  2011-06-24       Impact factor: 4.102

3.  Vascular smooth muscle Jak2 deletion prevents angiotensin II-mediated neointima formation following injury in mice.

Authors:  Annet Kirabo; S Paul Oh; Hideko Kasahara; Kay-Uwe Wagner; Peter P Sayeski
Journal:  J Mol Cell Cardiol       Date:  2011-03-17       Impact factor: 5.000

4.  Mineralocorticoid receptor expression in human venous smooth muscle cells: a potential role for aldosterone signaling in vein graft arterialization.

Authors:  Richard Bafford; Xin Xin Sui; Min Park; Takuya Miyahara; Brenna G Newfell; Iris Z Jaffe; Jose R Romero; Gail K Adler; Gordon H Williams; Raouf A Khalil; Michael S Conte
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-05-02       Impact factor: 4.733

Review 5.  Smooth muscle cell mineralocorticoid receptors: role in vascular function and contribution to cardiovascular disease.

Authors:  Amy McCurley; Adam McGraw; Dafina Pruthi; Iris Z Jaffe
Journal:  Pflugers Arch       Date:  2013-05-01       Impact factor: 3.657

Review 6.  Vascular Mineralocorticoid Receptor: Evolutionary Mediator of Wound Healing Turned Harmful by Our Modern Lifestyle.

Authors:  Lauren A Biwer; Mary C Wallingford; Iris Z Jaffe
Journal:  Am J Hypertens       Date:  2019-01-15       Impact factor: 2.689

7.  The novel mineralocorticoid receptor antagonist finerenone attenuates neointima formation after vascular injury.

Authors:  Jochen Dutzmann; Robert-Jonathan Musmann; Marco Haertlé; Jan-Marcus Daniel; Kristina Sonnenschein; Andreas Schäfer; Peter Kolkhof; Johann Bauersachs; Daniel G Sedding
Journal:  PLoS One       Date:  2017-09-19       Impact factor: 3.240

Review 8.  Mineralocorticoid receptor: A hidden culprit for hemodialysis vascular access dysfunction.

Authors:  Bohan Chen; Pei Wang; Andrew Brem; Lance Dworkin; Zhangsuo Liu; Rujun Gong
Journal:  EBioMedicine       Date:  2018-12-05       Impact factor: 8.143

Review 9.  Endothelial Dysfunction in Primary Aldosteronism.

Authors:  Zheng-Wei Chen; Cheng-Hsuan Tsai; Chien-Ting Pan; Chia-Hung Chou; Che-Wei Liao; Chi-Sheng Hung; Vin-Cent Wu; Yen-Hung Lin
Journal:  Int J Mol Sci       Date:  2019-10-21       Impact factor: 5.923

10.  Contribution of endogenous glucocorticoids and their intravascular metabolism by 11β-HSDs to postangioplasty neointimal proliferation in mice.

Authors:  Javaid Iqbal; Linsay J Macdonald; Lucinda Low; Jonathan R Seckl; Christopher W Yau; Brian R Walker; Patrick W F Hadoke
Journal:  Endocrinology       Date:  2012-11-02       Impact factor: 4.736

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.